Skip to main content

Histiocytic and Dendritic Cell Neoplasm clinical trials at UCSF

2 in progress, 1 open to eligible people

Histiocytic and dendritic cell neoplasm is a type of cancer. UCSF is conducting a clinical trial to study a new treatment called Selpercatinib. This trial is for people with advanced tumors, lymphomas, or histiocytic disorders that have a gene alteration called activating RET. There is one more trial in progress, but it is not accepting new participants at this time.

Showing trials for

Our lead scientists for Histiocytic and Dendritic Cell Neoplasm research studies include .

Last updated: